Skip to main content

Table 1 Comparison the demographic and clinical factors between 2 groups who received or not received chemotherapy

From: Does hysteroscopy in women with persistent gestational trophoblastic disease reduce the need for chemotherapy? A prospective, single-arm, clinical trial pilot study

 

Chemotherapy (+)

n = 2

Chemotherapy (−)

n = 28

Age

30 ± 1.4

31.5 ± 4.7

Gravidity

2 ± 1.4

2.4 ± 1.1

Baseline beta-hCG

29053 ± 5448

6561 ± 1718

Beta-hCG in day 7

5195 ± 331

2436 ± 604

  1. P value < 0.05 is significant
Back to article page